Jornal de Obesidade e Terapia para Perda de Peso

Abstrato

The Effect of Weight Losing to Benign Prostate Hyperplasia Patients with Metabolic Syndrome

LU Yong, LI Jin-lian, WU Yan-lin, PANG Shu-guang, HU Su1 and JIANG-Qiang

Objective: To explore the effect of weight losing to benign prostate hyperplasia patients with metabolic syndrome.

Methods: We chose 82 benign prostate hyperplasia patients who came for treatment in 2010 and divided them into group A and group B randomly. We measured body weight, height, and calculated body mass index, and we also measured blood pressure, fasting plasma glucose, total triglycerides, high density lipoprotein cholesterol, prostate specific antigen, prostate volume, and international prostate syndrome score. Group A received standard treatment; Group B got extra weight losing direction besides standard treatment. After six months, we compared the abovementioned measurements.
Results: BMI, prostate volume, international prostate syndrome score and total triglycerides in group B are significant lower than group A.
Conclusions On the basis of standard treatment metabolic syndrome patients with benign prostate hyperplasia
can benefit more from weight losing.